Cosmo Pharmaceuticals N.V. (LON:0RGI)
London · Delayed Price · Currency is GBP · Price in CHF 106.60
-2.40 (-2.20%)
Jan 7, 2026, 5:06 PM GMT
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.61 billion as of January 7, 2026. Its market cap has increased by 85.26% in one year.
Market Cap
1.61B
Enterprise Value
1.51B
Revenue
156.24M
Ranking
n/a
PE Ratio
31.40
Stock Price
106.60
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 82.45M to 1.61B, an increase of 1,858.64%. That is a compound annual growth rate of 17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 1.61B | 2.58% |
| Dec 30, 2025 | 1.57B | 74.80% |
| Dec 30, 2024 | 900.54M | 18.04% |
| Dec 29, 2023 | 762.90M | -15.23% |
| Dec 30, 2022 | 899.97M | 0.53% |
| Dec 30, 2021 | 895.23M | -12.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.48B |
| Haleon | 32.96B |
| Smith & Nephew | 10.35B |
| Convatec Group | 4.67B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.70B |